Search company, investor...

ExeVir Bio

exevir.com

Founded Year

2020

Stage

Loan | Alive

Total Raised

$76.36M

Last Raised

$26.71M | 1 mo ago

About ExeVir Bio

ExeVir Bio developed harnesses its Llama-derived antibody (VHH) technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. The company uses clinically validated VHH technology to help with treatments for viral infections. ExeVir Bio was founded in 2020 and is based in Gent, Belgium.

Headquarters Location

Rijvisschersstraat 120

Gent, 9052,

Belgium

Compete with ExeVir Bio?

Ensure that your company and products are accurately represented on our platform.

Expert Collections containing ExeVir Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ExeVir Bio is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest ExeVir Bio News

Funding round-up: BioVersys, ExeVir Bio, Volta Medical, Ganymed Robotics, Lapsi Health

Jan 31, 2023

The Netherlands: Lapsi Health, a healthtech startup developing sound-based medical technology (and software tools) to empower clinicians at the point of care and to enhance remote consultations, has raised US$3.7m in a Seed funding led by Sahir Ali of Modi Ventures, a Texas-based family office with investments in Artificial intelligence and Tech Bio. Modi Ventures was followed […]

ExeVir Bio Frequently Asked Questions (FAQ)

  • When was ExeVir Bio founded?

    ExeVir Bio was founded in 2020.

  • Where is ExeVir Bio's headquarters?

    ExeVir Bio's headquarters is located at Rijvisschersstraat 120, Gent.

  • What is ExeVir Bio's latest funding round?

    ExeVir Bio's latest funding round is Loan.

  • How much did ExeVir Bio raise?

    ExeVir Bio raised a total of $76.36M.

  • Who are the investors of ExeVir Bio?

    Investors of ExeVir Bio include European Investment Bank, VIB, La Societe Federale de Participations et d'Investissement, Fund+, V-Bio Ventures and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.